We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Rapid Test Uses Bacteria-Infecting Viruses to Accurately Identify UTI-Causing Pathogens

By LabMedica International staff writers
Posted on 31 Jul 2023
Print article
New rapid test uses bacteriophages to quickly and accur­ately identify UTI-causing pathogens (Photo courtesy of ETH Zurich)
New rapid test uses bacteriophages to quickly and accur­ately identify UTI-causing pathogens (Photo courtesy of ETH Zurich)

Cystitis affects approximately 50% of women at some point in their lives, with many experiencing recurring urinary tract infections. These bladder infections not only cause pain and potential complications but also present a significant challenge to healthcare providers. The rampant spread of antibiotic resistance in urinary tract infections often forces physicians to prescribe antibiotics indiscriminately without awareness of their effectiveness against the infection-causing pathogen. This is largely due to the lengthy period taken by conventional diagnostic methods to identify specific pathogens. Now, scientists have developed a rapid test that uses bacteriophages, viruses that naturally prey on bacteria, and have also altered them genetically to further increase their effectiveness in destroying pathogenic bacteria.

Bacteriophages, or simply phages, are highly specialized viruses. Each phage species infects only a particular bacterial type or strain. Scientists at ETH Zurich (Zurich, Switzerland) have harnessed this unique feature to develop a rapid test and a new therapeutic approach for urinary tract infections. Their initial step was identifying the most potent phages against the three primary bacteria types associated with urinary tract infections: Escherichia coli, Klebsiella, and Enterococci. The researchers then altered these naturally occurring phages in order to trigger the bacteria they recognize and infect to emit an easily detectable light signal. Using this technique, the researchers could reliably identify the disease-causing bacteria directly from a urine sample within four hours. This novel method could enable immediate prescription of the appropriate antibiotic after diagnosis, minimizing resistance development and promoting better antibiotic management.

The new method offers another advantage: it enables physicians to determine which patients might particularly benefit from personalized phage therapy, as the light signal strength in the assay indicates the phages' effectiveness in attacking the bacteria – the brighter the sample, the better the response to therapy. In a proof of concept study, the researchers enhanced the phages' efficacy by genetically modifying them. The altered phages not only generate new phages inside the host bacterium but also bacteriocins. These bacteria-killing proteins are especially potent against bacterial strains that have modified their surface parts to evade phage recognition, offering a two-pronged attack for enhanced treatment efficacy.

Nonetheless, the widespread application of such therapies in Western countries still has considerable obstacles to overcome. Aside from comprehensive clinical trials, regulatory amendments acknowledging phages as evolving biological entities that co-evolve with their bacterial hosts would be beneficial. The researchers' next step will involve testing the newly-developed phage therapy's efficacy in a clinical trial involving selected patients.

Related Links:
ETH Zurich

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: A false color scanning election micrograph of lung cancer cells grown in culture (Photo courtesy of Anne Weston)

AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell

Current strategies for matching cancer patients with specific treatments often depend on bulk sequencing of tumor DNA and RNA, which provides an average profile from all cells within a tumor sample.... Read more

Pathology

view channel
Image: Fingertip blood sample collection on the Babson Handwarmer (Photo courtesy of Babson Diagnostics)

Unique Hand-Warming Technology Supports High-Quality Fingertip Blood Sample Collection

Warming the hand is an effective way to facilitate blood collection from a fingertip, yet off-the-shelf solutions often do not fulfill laboratory requirements. Now, a unique hand-warming technology has... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.